Wong C, Gibbs P, Johns J, Jones I, Faragher I, Lynch E, Macrae F, Lipton L
Bio 21:MMIM Project, Melbourne, Victoria, Australia.
Intern Med J. 2008 May;38(5):328-33. doi: 10.1111/j.1445-5994.2007.01470.x. Epub 2007 Oct 3.
Unique research opportunities are being created in an era of increasingly sophisticated data collection and data linkage. There are Familial Cancer Clinics (FCC) to counsel patients and families about risk reduction strategies and to carry out genetic testing where appropriate. There is currently no objective evidence as to whether appropriate patients are being referred to the FCC.
Using a unique resource, the BIO21:MMIM informatics platform, we were able to link data from a prospective colorectal cancer (CRC) database at four Melbourne hospitals with the FCC database for the 4-year period from 2002 to 2005. We determined the number of patients that, on the basis of at least one risk factor suggestive of hereditary CRC, could have been considered for FCC referral, the number that was referred and the number that attended.
Of the 829 new diagnoses of CRC 228 (27.5%) would potentially have benefited from FCC referral. Of these, 50 persons (21.9%) were referred and 32 (14.0%) attended. The highest referral rates were in young, early-stage CRC patients with a family history and the lowest in late-stage and multiple-polyp patients. Patient sex, language and insurance status did not influence referral or attendance.
The database linkage capability provided by MMIM has enabled us to carry out a unique study. The results suggest that the rate of appropriate FCC referral is low, that certain subgroups are at particular risk of non-referral and that many referred patients do not ultimately attend. Interventions that increase referral rates and encourage attendance need to be considered.
在一个数据收集和数据关联日益复杂的时代,正在创造独特的研究机会。有家族性癌症诊所(FCC)为患者及其家属提供降低风险策略的咨询,并在适当情况下进行基因检测。目前尚无客观证据表明是否有合适的患者被转介至FCC。
利用独特的资源BIO21:MMIM信息学平台,我们能够将墨尔本四家医院前瞻性结直肠癌(CRC)数据库的数据与2002年至2005年4年期间的FCC数据库相链接。我们确定了基于至少一个提示遗传性CRC的风险因素本可被考虑转介至FCC的患者数量、被转介的数量以及实际就诊的数量。
在829例新诊断的CRC患者中,228例(27.5%)可能会从转介至FCC中受益。其中,50人(21.9%)被转介,32人(14.0%)实际就诊。转诊率最高的是有家族史的年轻早期CRC患者,最低的是晚期和多发息肉患者。患者的性别、语言和保险状况不影响转诊或就诊。
MMIM提供的数据库链接功能使我们能够开展一项独特的研究。结果表明,FCC的适当转诊率较低,某些亚组有不被转诊的特别风险,而且许多被转诊的患者最终并未就诊。需要考虑采取提高转诊率和鼓励就诊的干预措施。